Market Research Logo

Global Genomics Biomarkers Market 2017-2021

Global Genomics Biomarkers Market 2017-2021

About Genomics Biomarkers

A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).

Technavio’s analysts forecast the global genomics biomarkers market to grow at a CAGR of 17.59% during the period 2017-2021.Covered in this report

The report covers the present scenario and the growth prospects of the global genomics biomarkers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of genomic biomarkers.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Genomics Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Roche Diagnostics
  • Myriad Genetics
  • QIAGEN
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
Other prominent vendors
  • 23andMe
  • Aepodia
  • Almac Group
  • AROS Applied Biotechnology
  • DNAVision
  • Epigenomics
  • Epistem
  • Eurofins Scientific
  • Foundation Medicine
  • Genomic Health
  • Liquid Genomics
  • New England Biolabs
  • OriGene
  • US Biomarkers
Market driver
  • Genomics biomarker-based personalized medicine
  • For a full, detailed list, view our report
Market challenge
  • Delay in time from lab to market
  • For a full, detailed list, view our report
Market trend
  • Expansion of new business models
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Genomics Biomarkers Market 2017-2021

Technavio recognizes the following companies as the key players in the global genomics biomarkers market: Roche Diagnostics, Myriad Genetics, QIAGEN, Thermo Fisher Scientific, and Bio-Rad Laboratories.

Other Prominent Vendors in the market are: 23andMe, Aepodia, Almac, AROS Applied Biotechnology, DNAVision, Epigenomics, Epistem, Eurofins Scientific, Foundation Medicine, Genomic Health, Liquid Genomics, New England Biolabs, OriGene, and US Biomarkers.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is expansion of new business models. The evolution of biomarkers into clinical applications has changed the market for drugs and diagnostics. As per the evolving market opportunities, the pharmaceutical and diagnostic industries are opting for new business models. In the pharmaceutical industry, the drug development process, safety, and efficacy can be improved with the help of biomarkers.”

According to the report, one of the major drivers for this market is genomics biomarker-based personalized medicine. The use of high-throughput technologies provides a better understanding of the pathology of many diseases at the molecular level. This increased the development of new molecular-targeted treatments and enabled the discovery of molecular-based biomarkers like genomics biomarkers that are used in clinical studies.

Further, the report states that one of the major factors hindering the growth of this market is delay in time from lab to market. Since the rise of the supposed omics innovation, thousands of putative biomarkers have been distinguished and published, which have drastically expanded the options for growing more viable therapeutics. These opportunities have significant advantages for patients and for the financial matters of healthcare services. There are a number of challenges for bringing the biomarkers from the clinical research lab to the market, which are time consuming.

Companies Mentioned

Roche Diagnostics, Myriad Genetics, QIAGEN, Thermo Fisher Scientific, Bio-Rad Laboratories, 23andMe, Aepodia, Almac, AROS Applied Biotechnology, DNAVision, Epigenomics, Epistem, Eurofins Scientific, Foundation Medicine, Genomic Health, Liquid Genomics, New England Biolabs, OriGene, US Biomarkers.

  • Executive summary
  • Scope of the report
    • Market overview
      • Table Important DNA and RNA characteristics of a genomic biomarker
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table The biomarkers discovery strategies
      • Table The value chain on genomics biomarkers
  • Market landscape
    • Market overview
      • Table Global genomics biomarkers overview
    • Market size and forecast
      • Table Global genomics biomarkers market ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by indication
    • Table Global genomics biomarkers market by indication
    • Table Market scenario of genomics biomarkers in oncology
    • Table Market scenario of genomics biomarkers in cardiovascular diseases
    • Table Market scenario of genomics biomarkers in neurological diseases
  • Market segmentation by end-user
    • Table Global genomics biomarkers market share by end-user
    • Diagnostic and research laboratories
    • Hospitals
  • Geographical segmentation
    • Table Global genomics biomarkers market by geography 2016 (% revenues)
    • Genomics biomarkers market in Americas
      • Table Genomics biomarkers market in Americas overview
      • Table Genomics biomarkers market in Americas ($ billions)
      • Table Market analysis of genomics biomarkers in Americas
    • Genomics biomarkers market in EMEA
      • Table Genomics biomarkers market in EMEA overview
      • Table Genomics biomarkers market in EMEA ($ billions)
      • Table Market analysis of genomics biomarkers in EMEA
    • Genomics biomarkers market in APAC
      • Table Genomics biomarkers market in APAC overview
      • Table Genomics biomarkers market in APAC ($ millions)
      • Table Market analysis of genomics biomarkers in APAC
  • Market drivers
    • Increasing low-cost clinical trials in developing countries
    • Improving research network infrastructures
      • Table Some of the prominent consortia for development of biomarkers
    • Genomics biomarker-based personalized medicine
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Reproducibility of genomic biomarkers and tests leading to discrepancies
      • Table Criteria for acceptable biomarker-based test
    • Delay in time from lab to market
    • Reimbursement challenges for genomics biomarkers-based tests
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Improvement in care delivery with advances in genomics technologies
      • Table Techniques used in arriving at single-cell biology
      • Table Trends and innovators in genomic technologies
    • Expansion of new business models
    • Development of affordable genomic biomarkers as diagnostics for tropical diseases
  • Vendor landscape
    • Table Global genomics biomarkers market competitor rankings 2016
    • Table Competitive structure analysis of global genomics biomarkers market 2016
    • Table Global genomics biomarkers market-competitive landscape
    • Table Game-changing strategies for market participants
  • Key vendor analysis
    • Roche Diagnostics
      • Table Roche Diagnostics strength assessment
      • Table Roche Diagnostics strategy assessment
      • Table Roche Diagnostics opportunity assessment
    • Myriad Genetics
      • Table Myriad Genetics strength assessment
      • Table Myriad Genetics strategy assessment
      • Table Myriad Genetics opportunity assessment
    • QIAGEN
      • Table QIAGEN strength assessment
      • Table QIAGEN strategy assessment
      • Table QIAGEN opportunity assessment
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific strength assessment
      • Table Thermo Fisher Scientific strategy assessment
      • Table Thermo Fisher Scientific opportunity assessment
    • Bio-Rad Laboratories
      • Table Bio-Rad Laboratories strength assessment
      • Table Bio-Rad Laboratories strategy assessment
      • Table Bio-Rad Laboratories opportunity assessment
    • Other prominent vendors
      • Table Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report